Revvity (RVTY) Free Cash Flow Growth (1y) (2010 - 2026)
Revvity (RVTY) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 16.06% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -173.96% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 23.29% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 112.68% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 33.01% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -42.16% |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 56.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 56.67% |
| Apr 5, 2026 | -10.16% |
| Dec 28, 2025 | 7.14% |
| Sep 28, 2025 | -10.85% |
| Jun 29, 2025 | -27.98% |
| Mar 30, 2025 | -10.72% |
| Dec 29, 2024 | -58.12% |
| Sep 29, 2024 | 341.21% |
| Jun 30, 2024 | 201.79% |
| Mar 31, 2024 | 160.81% |
| Dec 31, 2023 | 185.47% |
| Apr 2, 2023 | -83.04% |
| Apr 3, 2022 | -34.85% |
| Oct 3, 2021 | 51.38% |
| Jul 4, 2021 | 119.36% |
| Apr 4, 2021 | 1,060.68% |
| Jan 3, 2021 | 147.89% |
| Oct 4, 2020 | 112.20% |
| Jul 5, 2020 | 302.82% |
| Apr 5, 2020 | 257.05% |